@misc{indiciae80c9968b13e7,
  title = {COMBINATION THERAPIES TARGETING ALK-ABERRANT NEUROBLASTOMA IN PRECLINICAL MODELS.},
  author = {Tucker, E. and Jimenez, I. and Chen, L. and Bellini, A. and Gorrini, C. and Calton, E. and Gao, Q. and Che, H. and Poon, E. and Jamin, Y. and Martins da Costa, B. and Barker, K. and Shrestha, S. and Hutchinson, C. and Dhariwal, S. and Goodman, A. and Del Nery, E. and Gestraud, P. and Bhalshankar, J. and Iddir, Y. and Saberi-Ansari, E. and Saint-Charles, A. and Geoerger, B. and Marques Da Costa, J. and Pierre-Eugene, C. and Janouiex, I. and Decaudin, D. and Nemati, F. and Carcaboso, A. and Surdez, D. and Delattre, O. and George, S. and Chesler, L. and Tweddle, D. and Schleiermacher, G.},
  year = {2022},
  doi = {10.1101/2022.10.30.512477},
  url = {https://www.biorxiv.org/content/10.1101/2022.10.30.512477v1},
  note = {Source identifier: 10.1101/2022.10.30.512477}
}